- Home
- INMD vs BSTZ Comparison
INMD vs BSTZ Comparison
Compare INMD & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- BSTZ
- Stock Information
- Founded
- INMD 2008
- BSTZ 2019
- Country
- INMD Israel
- BSTZ United States
- Employees
- INMD N/A
- BSTZ N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BSTZ Trusts Except Educational Religious and Charitable
- Sector
- INMD Health Care
- BSTZ Finance
- Exchange
- INMD Nasdaq
- BSTZ Nasdaq
- Market Cap
- INMD 1.5B
- BSTZ 1.5B
- IPO Year
- INMD 2019
- BSTZ N/A
- Fundamental
- Price
- INMD $17.06
- BSTZ N/A
- Analyst Decision
- INMD Buy
- BSTZ
- Analyst Count
- INMD 6
- BSTZ 0
- Target Price
- INMD $22.60
- BSTZ N/A
- AVG Volume (30 Days)
- INMD 873.9K
- BSTZ 303.2K
- Earning Date
- INMD 02-11-2025
- BSTZ 01-01-0001
- Dividend Yield
- INMD N/A
- BSTZ 8.31%
- EPS Growth
- INMD N/A
- BSTZ N/A
- EPS
- INMD 1.84
- BSTZ 0.71
- Revenue
- INMD $423,746,000.00
- BSTZ N/A
- Revenue This Year
- INMD N/A
- BSTZ N/A
- Revenue Next Year
- INMD $3.13
- BSTZ N/A
- P/E Ratio
- INMD $9.23
- BSTZ $26.69
- Revenue Growth
- INMD N/A
- BSTZ N/A
- 52 Week Low
- INMD $14.87
- BSTZ $14.11
- 52 Week High
- INMD $26.80
- BSTZ $19.43
- Technical
- Relative Strength Index (RSI)
- INMD 33.31
- BSTZ 60.15
- Support Level
- INMD $16.96
- BSTZ $20.20
- Resistance Level
- INMD $17.74
- BSTZ $22.08
- Average True Range (ATR)
- INMD 0.60
- BSTZ 0.38
- MACD
- INMD -0.23
- BSTZ -0.05
- Stochastic Oscillator
- INMD 0.02
- BSTZ 94.41
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.